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Abstract 
Melatonin is a neurohormone, chronobiotic and antioxidant compound found in wine and deriving 
directly from grapes and/or synthesized by yeast during alcoholic fermentation. In addition, a 
melatonin isomer has been detected in different foods, wine among them. The special interest for 
melatonin isomer related to the fact that it was found in greater quantities than melatonin, and 
probably shares some of its biological properties. Despite this, its chemical structure has not yet 
been defined; although some researchers hypothesize it could be melatonin with the 
ethylacetamide group shifted into position N1. Thus, the aim of our study was to identify the 
structures of the melatonin isomer. For this purpose, melatonin and melatonin isomer in Syrah wine 
were separated chromatographically by a sub-2 μm particle column and detected by tandem mass 
spectrometry. The sample was then purified and concentrated by solid-phase extraction, hydrolyzed 
with alkali or esterase, and substrates and products quantified by UPLC-MS/MS. Moreover, 
melatonin, melatonin isomer and their product ions were evaluated by high-resolution mass 
spectrometry. The amount of melatonin isomer and melatonin in the wine was 84±4 and 3±0 ng/mL, 
respectively. In the solutions, containing diluted alkali or esterase, melatonin isomer was hydrolyzed 
in about 8 min. Correspondingly, tryptophan was detected and its amount increased and reached 
the maximum concentration in about 8 min. Melatonin concentration was not affected by diluted 
alkali or esterase. The fragmentation pattern of melatonin isomer was different from that of 
melatonin but comparable to that of tryptophan-ethylester. Finally, the so-called melatonin isomer 
identity was verified by co-chromatography with authentic standard of tryptophan-ethylester. 
 
Introduction 
Melatonin (N-acetyl-5-methoxytryptamine), produced mainly by the pineal gland in vertebrates, is 
synthesized from tryptophan via serotonin [1]. In animals, melatonin typically appears in the pineal 
gland but it was found also in other tissues [2], and it seems to be synthesized also in the intestine 
[3]. In humans, melatonin modulates physiological processes, such as circadian rhythms and 
reproductive functions, and possesses antioxidant properties as well [4]. The latter seems to be 
correlated with an increased longevity [5], the development of protective mechanisms against 
mutations [6], and it affects the immune system [7]. Moreover, the melatonin’s protective actions 
have beneficial effects on memory processes [8] and in the treatment of several diseases such as 
Alzheimer’s [9, 10] and amyotrophic lateral sclerosis [11].  
Melatonin is found in a variety of foods [12] including edible plants [13-15], fruits [16-18], 
and beverages [19]. Melatonin is also detected in wine, and several researchers have related its 
presence to the activity of the yeast involved in the fermentation process [20-22]. Other authors 
have recently found melatonin in grapes and other tissues, suggesting that it was already present in 
the substrate [23, 24]. In both cases, the experimental evidences are still scarce. Thus, the relation 
among melatonin, its substrate and wine yeast necessitates further study, especially considering that 
reported studies were focused exclusively on melatonin production by Saccharomyces yeasts, 
ignoring any other non-Saccharomyces species.  
Analyzing melatonin in wine by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was 
first reported by Rodriguez-Naranjo et al. [25] the presence of a melatonin-like compound. They also 
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found it had the same molecular mass and shared several main product ions with melatonin such as 
the ions with m/z 174 and 216. On the other hand, in MS/MS this unknown compound gave also 
minor product ions not found in the melatonin fragmentation pattern, and they eluted earlier than 
melatonin. Thus, it was called a melatonin-isomer. Subsequently melatonin and the melatonin 
isomer were found in different wine varieties [18, 26] and foods such as beer, yogurt and bread [12, 
27].  
Yilmaz et al. [27] reported that Saccharomyces cerevisiae was ineffective in changing the 
melatonin concentration during bread dough fermentation, while the melatonin isomer amount 
increased. Gomez et al. [26] found the increase in melatonin isomer during a laboratory-scale 
winemaking process and in an aqueous medium containing yeast and nutrient, suggesting that the 
yeasts were responsible for the melatonin isomer formation. Moreover, their data also 
demonstrated that the amount of the melatonin isomer formed during wine fermentation was not 
related to the melatonin concentration [28]. This suggested that melatonin isomer probably did not 
derive from the biosynthetic pathway of melatonin, but rather it was produced by a different 
pathway.  
The reported amount of melatonin in wine ranges from pg to ng/mL, and the quantitative 
differences could be attributed to different brands of wine, different strains of yeast or the 
employment of non-appropriate analytical methods. To evaluate the influence of the analytical 
method, Rodriguez-Naranjo et al. [25] estimated the melatonin levels in the same wine applying two 
of the most frequently used methods: the ELISA and LC-MS/MS. The reported results showed that 
melatonin levels measured by LC-MS/MS were higher than those obtained by ELISA up to the three 
orders of magnitude, and the ELISA method failed to identify melatonin isomer. Thus, the authors 
concluded that ELISA was not a reliable method for quantifying melatonin  in wines. Regarding 
melatonin isomer, the highest amount detected in red wine was 170 ng/mL [18, 25-26]. Thus, 
melatonin isomer level in wine is generally higher than that of melatonin, and also for this reason MI 
has attracted much attention. Unfortunately, its identification is difficult due to different factors 
such as the lack of reference standard, low concentrations in the food samples that makes difficult 
its purification for the NMR analysis, and the large number of potential isomers. In this regard, Tan 
et al. [28] calculated that 42 combinations could be possible considering only the positions of the 
two side chains linked to the indole ring. The authors have proposed a nomenclature for the MI 
identification. To date, only N-acetyl-3-(2-aminoethyl)-6-methoxyindole is available as a standard. 
Rodriguez-Naranjo et al. [25] excluded it due to the different pattern of fragmentation and for its 
later chromatographic retention in comparison to melatonin isomer. Based on the data of 
Diamantini et al. [29], several authors [12, 26-28] identified melatonin isomer as 1-(2-
alkanamidoethyl)-6-methoxyindole.  
The aim of our study was to identify the main isomer of melatonin present in red wine. For 
this purpose, we applied the ultra-performance liquid chromatography coupled to high-resolution 
mass spectrometry (UPLC-HR-MS) and performed the fragmentation of analytes by HR-MS/MS. 
Subsequently, we also purified the wine sample by solid-phase extraction (SPE), hydrolyzed with 
alkali or esterase, detected and quantified the substrates as well as the products by UPLC-MS/MS. 
Finally, we verified the MI identity by co-chromatography with a commercially available reference 
standard. 
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Materials and methods 
Chemicals 
Melatonin, tryptophan-ethyl ester (tryptophan-EE), tryptophan  and esterase from porcine liver (EC 
3.1.1.1) were provided by Sigma-Aldrich (St. Louis, MO, USA). Methanol, boric and formic acids were 
from Merck (Darmstadt, Germany). Red wine (Syrah, Settesoli DOC 2012) was acquired in a local 
market, and ultrapure water was obtained from a MilliQ apparatus (Millipore, Milford, MA, USA). 
 
Sample preparation for hydrolysis 
Syrah wine aliquot (10 mL) was loaded on a 500 mg StrataX SPE column (Phenomenex, 
Torrence, CA, USA) pre-activated by 4 mL methanol followed by 8 mL of 0.1% formic acid 
in water. The column was washed with 5 mL of 0.1% formic acid and 5 mL of 70% 
methanol, dried under vacuum and eluted with 3 mL of methanol. The eluate was then dried 
under vacuum, the residue suspended in 1 mL of MilliQ-treated water, centrifuged at 1000 x 
g for 2 min, and the clear solution used for the hydrolysis tests. 
 
Hydrolysis by alkali 
Purified wine solution (0.2 mL) was incubated with 0.02 mL of 0.1 N NaOH and 0.1 mL of 
melatonin (1.0 µg/mL in water) at 30°C. Twenty µL of reaction mixture were collected at 0, 
5, 10, 15, 20, 25, 30 min time points and diluted up to 40 µL with 0.1 N HCl. The solutions 
were subsequently diluted with methanol, centrifuged at 1000 x g for 1 min and the resulting 
supernatant analyzed by UPLC-MS/MS. The purified wine solution and melatonin were used 
as the controls. 
Hydrolysis by esterase 
One mL of the wine solution was incubated with 1 mL of esterase (5x10-4, 1x10-3, 5x10-3 U) 
in 10 mM borate buffer (pH 7.5) and 100 μL of melatonin (5 µg/mL in water) at 25°C. At 
time zero, every 1 min for 10 min, and after 15, 20, 25, 30 min, 50 µL of reaction mixture 
were collected and diluted up to 0.1 mL with methanol. The resulting solutions were 
subsequently diluted with methanol and centrifuged at 1000 x g for 1 min. The resulting 
supernatants were analyzed by UPLC-MS/MS. Wine, melatonin and esterase borate solutions 
were used as the controls. 
UPLC-MS/MS analysis 
The UPLC-MS/MS analysis was carried out on an Acquity UPLC separation module (Waters, Milford, 
MA, USA) coupled with a triple quadrupole mass spectrometer Quattromicro (Waters). A 1.7 μm 
BEH C18 column (100x2.1 mm, Waters) was used for separation. The eluents were 0.1% formic acid in 
MilliQ-treated water (solvent A) and methanol (solvent B). Ten µL of the sample were separated by 
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the UPLC using the following elution gradient: 5–60% B in 6 min and then 60–100% B in 3 min at a 
flow-rate of 0.55 mL/min. The column and samples were kept at 40 and 20°C, respectively. The 
capillary voltage was set to 3.0 kV, the cone voltage was 14 V, the source temperature was 130°C, 
the desolvating temperature was 350°C, the collision energy was 16 V, and argon was used at 
2.1x10-3 mbar to improve fragmentation in the collision cell. Melatonin, melatonin isomer, 
tryptophan, and tryptophan-EE were determined in multiple reaction monitoring (MRM) mode, and 
the data were acquired by MassLynx 4.0 software (Waters). The mass spectrometer was operated in 
the electrospray ionization (ESI) positive mode and the fragmentation transitions were (m/z)
+ 
233→174 for melatonin, tryptophan-EE and melatonin isomer, and (m/z)
+
 205→188, 146, 118 for 
tryptophan, with a dwell time of 0.15 sec. To keep the cone clear, the eluate from the first 1.1 min 
analysis was discarded by the divert valve. Calibration curves were obtained from melatonin, 
tryptophan, and tryptophan-EE stock solutions prepared by dissolving 10 mg of standard powder in 
10 mL methanol, and their quantitative determination performed in the range 0.2–20 ng/mL. 
 
UPLC-HR-MS analysis 
The UPLC-HR-MS analysis was carried out on an Acquity UPLC separation module (Waters) coupled 
with a Q-Exactive hybrid quadrupole-Orbitrap MS through an HESI-II probe for electrospray 
ionization (Thermo Scientific, San Jose, CA, USA). The ion source and interface conditions were: 
spray voltage 3.5 kV, sheath gas flow rate 35, auxiliary gas flow rate 15 and temperature 250 °C, 
capillary temperature 350 °C. Two μL of each sample were separated on an ACQUITY UPLC HSS C18 
column (100×2.1 mm, 1.8 μm) (Waters) kept at 50 °C. The eluents were 0.1% formic acid in MilliQ-
treated water (solvent A) and methanol (solvent B). The UPLC separation was performed by using a 
linear elution gradient (5% to 100% of solvent B in 6.9 min) at a flow rate of 0.55 mL/min. The UPLC 
eluate was analyzed by MS using Full MS (<5 ppm mass tolerance) and targeted MS2 analysis (t-MS2). 
The resolution was set at 70K and 17.5K for Full MS and t-MS2 scan types, respectively. The AGC 
target was 5E5 for Full MS and 2E5 for t-MS2 scans. The maximum ion injection time was 200 and 
100 ms for Full MS and t-MS2 scans, respectively. The collision energy was 10, 20, 30, 40, 50 or 60 V 
for t-MS2. The MS data were processed using Xcalibur software (Thermo Scientific). 
 
Results and Discussion 
To the best of our knowledge, this is the first paper reporting the characterization of the unknown 
compound found in wine and different foods, called melatonin isomer. 
In a previous work [18] in different wines we found unknown compounds tentatively identified as 
melatonin isomers according to the tandem mass spectrometry data. Among these, the one 
characterized by the earliest retention (melatonin isomer) was the most abundant, and its quantity 
was up to 72 ng/mL in a sample of Syrah wine. For this reason, Syrah wine was used in this study. 
A good separation of the tryptophan (RT 1.8 min), “melatonin isomer” (RT 2.8 min), tryptophan-EE 
(RT 2.8 min) and melatonin (RT 3.4 min) was achieved with a BEH C18 sub-2 μm particle column and 
under gradient mode elution. The amount of tryptophan, melatonin isomer and melatonin in the red 
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wine was 152±9, 84±4 and 3±0 ng/mL, respectively. The percentage recovery values of the SPE 
extraction for the melatonin isomer and melatonin from red wine samples were 70±3 and 90±4%, 
respectively. We used the lower melatonin isomer recovery elution conditions with the aim to 
reduce the amount of tryptophan present in the red wine. Thus, the amount of tryptophan, 
melatonin and melatonin isomer in the purified wine sample was 12±2, 27±2 and 588±25 ng/ml, 
respectively.   
As expected, hydrolysis reaction of the blank solutions demonstrated that melatonin and 
melatonin isomer amount did not change. Sodium hydroxide rapidly degraded melatonin isomer 
within the first 5 min of incubation, and melatonin isomer was no more detectable in the 
subsequent 5 min (data not shown). On the contrary, the concentration of melatonin was not 
affected by the action of the sodium hydroxide. The results obtained by nonspecific hydrolytic 
conditions, such as that with alkali, suggested that melatonin isomer, in contrary to melatonin, 
contained an easily hydrolysable bond, which could be the ester. To confirm/reject this hypothesis 
melatonin isomer was subsequently hydrolyzed using a specific enzyme such as esterase. We tested 
three different esterase concentrations (as indicated in Materials and Methods) and selected the 
optimal one to obtain a degradation kinetic (data not shown). Figure 1 shows the time-course of 
melatonin, melatonin isomer and tryptophan in a batch containing 5x10-4 U of esterase. As it was 
expected, melatonin and melatonin isomer amount did not change in the blank solutions in 30 min 
(data not shown). On the contrary, in the solutions containing esterase about 50% of melatonin 
isomer disappeared in 4 min, and after 8 min it was no longer detectable. Correspondingly, 
tryptophan increased slowly in the first two min and then reached the maximum concentration in 
about 8 min. Once formed, it was stable up to 30 min incubation with esterase (data not shown). 
Moreover, the tryptophan amounts detected in the hydrolysis batches were about 10% higher than 
those stoichiometrically produced by melatonin isomer, suggesting that melatonin isomer could be 
one of the main sources of tryptophan, but not the single one. Regarding melatonin, its 
concentration was not affected by the action of the esterase. 
 
Melatonin, melatonin isomer and tryptophan-EE were analyzed by ESI-HR-MS in the positive ion 
mode as these conditions were more sensitive, and analytes gave a better fragmentation pattern 
during collision induced-dissociation (CID). High-resolution MS analysis showed that the most 
abundant ion of melatonin, melatonin isomer and tryptophan-EE had a m/z of 233.1285, 
corresponding to monoprotonated molecule ([M+H]+). In the fragmentation spectra of melatonin, 
obtained in the collision energy range 10–60 V, the main product ion had m/z 174.0913 (fa), which 
could be justified by the cleavage of the CH2-N bond with H rearrangement. As shown in figure 2, the 
ion fa could be generated by fragmentation of the ion d and e or directly by the protonated 
melatonin though the loss of CH3CONH2 moiety [29, 30]. The ions d and e were found only at lower 
collision energies and in a much smaller amount compared to the ion fa. At higher collision energies 
the ions g, h and i were also found (Fig. 2). The formation of these ions was probably due to an initial 
rearrangement of the ion fa, favored by the acquisition of aromaticity, giving the ion A, which easily 
lost a methyl group to give the ions g. The ion ia, a radical product, could also result from the 
homolytic cleavage of the ion fa. This behavior was probably dependent on the presence of the 
double bond conjugated to the indole ring system and the subsequent production of a stable indolic 
radical. Even in the fragmentation pattern of the tryptophan-EE and melatonin isomer homolytic 
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cleavages were present (Fig. 3), as in production of the ions q and h. It is important to underline that 
also in this case the C-C double bound conjugated to the indole system was broken. In contrary, the 
fragmentation of tryptophan-EE (Fig. 3) as the main product gave the ion d, which was generated by 
the cleavage of the NH2 group and formation of a C-C double bound in the alkyl chain. At higher 
collision energies product ions different from those produced by melatonin appeared: the ion l, 
derived from the loss of the ethyl group by d, the ions n, o, p, q, r, s and t. It should be emphasized 
that both melatonin and tryptophan-EE during CID produced ions with m/z 174.0919 (fa and fb), 
which presumably corresponded to different structures depending on the parent ion (Fig. 2 and Fig. 
3). The ions fb, produced by tryptophan-EE, underwent heterolytic rupture, unlike that produced by 
melatonin, and during CID the ions p were formed. The same product ions with the same relative 
intensities were found in the fragmentation pattern of the unknown compound found in the red 
wine and called “MI”. As shown in table 1, melatonin and tryptophan-EE gave product ions with m/z 
159.0684 (g) and 159.0922 (n), respectively. The difference of 23 mDa suggested that the two 
product ions were structurally different, and therefore tryptophan-EE and melatonin isomer had a 
fragmentation pattern partially different from that of melatonin. This difference was not detected 
using low-resolution MS, such as the triple quadrupole. The result highlights that HR-MS/MS should 
be the preferred technique in fragmentation studies. 
 
  Considering the data obtained by HR-MS, HR-MS/MS, co-chromatography and enzymatic 
hydrolysis, it could be presumed that the unknown compound, called melatonin isomer, is likely the 
tryptophan-EE. The presence of tryptophan-EE in wine is not surprising. In fact, some authors 
reported the presence of several ethyl esters of amino acids (AA-EEs) in sherries and wines, and in 
latters their concentrations were up to 58 mg/L [26, 27]. Thus, AA-EEs are an important group of 
compounds present in wines. AA-EEs are formed during the alcoholic fermentation by yeasts [32]. 
Their formation mainly occurs in the second half of the fermentation, when the ethanol content in 
the medium is higher. When the yeast remains in contact with the wine, as it happens at the end of 
the fermentation, the amount of AA-EEs increases. Some differences were found between the yeasts 
used for the wine production. Thus, in contrary to melatonin, AA-EEs such as tryptophan-EE derive 
solely from the yeast activity.  
  Gomez et al. [26] reported that during a laboratory-scale winemaking process the yeast 
Saccharomyces played a decisive role in the production of melatonin isomer but not in that of 
melatonin, and the amount of melatonin isomer was higher at the end of fermentation period. The 
authors also reported that, in an aqueous media containing yeasts and tryptophan, only the 
concentration of melatonin isomer increased, and it was time-dependent. Moreover, the presence 
of tryptophan in must stimulates the occurrence of the melatonin isomer. Yilmaz et al. [27] 
investigated the formation of melatonin and melatonin isomer as well as the changes in free AAs, 
especially tryptophan, during bread fermentation and baking. They found that melatonin amount 
did not change significantly during dough fermentation, whereas melatonin isomer content 
increased up to 17 ng/g. Moreover, at the end of the baking process tryptophan decreased by 58%. 
Overall, these data support our hypothesis that the main “melatonin isomer” described in literature 
is the tryptophan-EE.  
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Tryptophan ethyl ester dilates in vitro small mesenteric arteries [33] and was used by Jonas 
and Butler [34] to bypass defective gastrointestinal AA transport in a child with Hartnup disease. The 
authors reported that the normalization of the serum tryptophan concentration was reached by a 
sustained treatment with 20 mg/kg of TRP each 6 h, the amount clearly not achievable with the 
regular diet. Moreover, the authors stated that tryptophan-EE hydrolysis during absorption was 
apparently complete, since only tryptophan was detected in serum. In this regard, the authors 
reported that the lower limit of detection of the tryptophan-EE in serum was approximately 90 
ng/mL. The latter is an higher value considering that melatonin levels are in the order of pg/mL. 
Thus, the presence of tryptophan-EE in plasma at concentrations lower than nM cannot be excluded. 
Finally, tryptophan-EE ingested with the diet provides a poor amount of tryptophan, which could be 
transformed into melatoninin the gastrointestinal tract, as reported by Konturek et al. [35]. 
Summing up, the identity of this molecule makes it less interesting than the supposed melatonin 
isomer from the nutritional point of view, mainly considering the small amounts present in food. 
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Figure Legends 
Figure 1. Kinetics of Melatonin (□), Melatonin isomer (○) and Tryptophan (∆) during hydrolysis by 
esterase of purified and concentrated red wine sample. Data are reported as means. The 
average initial concentration of Tryptophan was 0.03 nmol/mL. 
 
Figure 2.  Main fragmentation patterns of the protonated Melatonin. The protonated product ions 
were obtained by High Resolution CID in the range 10-60 V. See Table 1 for product ion 
identification. 
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Figure 3. Formation of protonated product ions after Tryptophan-EE or Melatonin isomer 
fragmentation. The fragmentations were obtained in HR-MS/MS with collision energy in 
the range 10-60 V. See Table 1 for product ion identification.  
 
Table 1. Parent ion and fragments obtained by UPLC-HR-MS/MS of standard of melatonin, 
tryptophan-ethyl ester and melatonin isomer in purified red wine. 
 
MF: protonated molecular formula.  
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